Compositions comprising an RNA polymerase inhibitor and cyclodextrin for treating viral infections
US11266681B2 · kind B2 · utility
23Cited by
77References
45Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 1, 2020 |
| Grant date | Mar 8, 2022 |
| Priority date | — |
| Expiry date | May 1, 2040 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P31/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure provides a composition comprising Compound 1, or a pharmaceutically acceptable salt thereof, cyclodextrin, and, optionally, pH adjusting agents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.